Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience

BMC Research Notes

Jan Boström¹  Alexander Grote¹  Nina-Christine Kanther¹  Azize Boström¹ 

[1] Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Str. 25, Bonn 53105, Germany

关键词: Electrophysiology;    Follow-up;    Outcome;    Tumours;    Intramedullary;   

Others  :  1092068
DOI  :  10.1186/1756-0500-7-908

 received in 2014-03-16, accepted in 2014-12-11,  发布年份 2014

【 摘 要 】

Background

Several uncertainties remain concerning the management of intramedullary spinal cord tumours (IMSCTs). These include the timing and extent of resection, its interrelated functional outcome, and the adequate use and timing of radiation therapy and/or chemotherapy. In this retrospective study we report on all adult cases involving IMSCTs treated from 1987 to 2007 in our institution to validate our treatment strategy for IMSCTs. Pre- and post-operative functional performance was classified according to the McCormick scale.

Results

A total of 70 adult cases with IMSCTs consisting of ependymoma (39), astrocytoma (11), carcinoma metastasis (8), haemangioblastoma (5), cavernoma (3) and others (4) were reviewed. Mean age was 46.8 years (range, 18-79 years), and mean follow-up was 4.5 years (range, 1-195 months). The proportion of localisation in descending order was thoracic (36%), cervical (33%), cervicothoracic (19%) and conus region (13%), with 45 gross total resections, 22 partial resections and three biopsies. Surgery-related morbidity with worsening postoperative symptoms occurred immediately in 13 patients (18.6%). The preoperative McCormick grade correlated significantly with the early postoperative grade and the grade at follow-up (χ²-test; p = 0.001). None of the patients with preserved intraoperative evoked potentials exhibited significant postoperative deterioration. The degree of resection was correlated with progression-free survival (Duncan test; p = 0.05). Most patients with malignant tumours, namely anaplastic ependymoma (3), astrocytoma (2) or metastatic lesions (5), underwent postoperative radiation therapy. Six patients (one anaplastic ependymoma, two anaplastic astrocytomas and three metastatic lesions) received postoperative chemotherapy.

Conclusions

IMSCTs should be operated on when symptoms are mild. We recommend evoked potential-guided microsurgical total resection of ependymomas and other benign lesions; partial resection or biopsy followed by adjuvant therapy should be confined to patients with high-grade astrocytomas, whereas resection or biopsy with adjuvant therapy is the best option for metastatic lesions.

【 授权许可】

   
2014 Boström et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Klekamp J, Samii M: Surgery of spinal tumors. Berlin – Heidelberg: Springer; 2007.
• [2]Manzano G, Green BA, Vanni S, Levi AD: Contemporary management of adult intramedullary spinal tumors – pathology and neurological outcomes related to surgical resection. Spinal Cord 2008, 46(8):540-546.
• [3]Antoniadis G, Engelhardt M, Börm W, Richter HP, Rath SA: Spinale intramedulläre Tumoren. Wann ist die operative Behandlung angezeigt? Nervenarzt 2005, 76(2):186-192.
• [4]Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G: Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery 2005, 56(5):972-981.
• [5]McCormick PC, Torres R, Post KD, Stein BM: Intramedullary ependymoma of the spinal cord. J Neurosurg 1990, 72(4):523-532.
• [6]Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP: Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys 2009, 73(3):727-733.
• [7]Patil CG, Patil TS, Lad SP, Boakye M: Complications and outcomes after spinal cord tumor resection in the United States from 1993 to 2002. Spinal Cord 2008, 46(5):375-379.
• [8]Sandalcioglu IE, Gasser T, Asgari S, Lazorisak A, Engelhorn T, Egelhof T, Stolke D, Wiedemayer H: Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord 2005, 43(1):34-41.
• [9]Costa P, Bruno A, Bonzanino M, Massaro F, Caruso L, Vincenzo I, Ciaramitaro P, Montalenti E: Somatosensory- and motor-evoked potential monitoring during spine and spinal cord surgery. Spinal Cord 2007, 45(1):86-91.
• [10]Kothbauer KF, Deletis V, Epstein FJ: Motor-evoked potential monitoring for intramedullary spinal cord tumor surgery: correlation of clinical and neurophysiological data in a series of 100 consecutive procedures. Neurosurg Focus 1998, 4(5):E1.
• [11]Morota N, Deletis V, Constantini S, Kofler M, Cohen H, Epstein FJ: The role of motor evoked potentials during surgery for intramedullary spinal cord tumors. Neurosurgery 1997, 41(6):1327-1336.
• [12]Sala F, Bricolo A, Faccioli F, Lanteri P, Gerosa M: Surgery for intramedullary spinal cord tumors: the role of intraoperative (neurophysiological) monitoring. Eur Spine J 2007, 16(Suppl 2):130-139.
• [13]Matsuyama Y, Sakai Y, Katayama Y, Imagama S, Ito Z, Wakao N, Sato K, Kamiya M, Yukawa Y, Kanemura T, Yanase M, Ishiguro N: Surgical results of intramedullary spinal cord tumor with spinal cord monitoring to guide extent of resection. J Neurosurg Spine 2009, 10(5):404-413.
• [14]Garcés-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL: Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. J Neurosurg Spine 2009, 11(5):591-599.
• [15]Nakamura M, Ishii K, Watanabe K, Tsuji T, Takaishi H, Matsumoto M, Toyama Y, Chiba K: Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord 2008, 46(4):282-286.
• [16]Bostrom A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Bostrom JP, Schramm J, Simon M: Surgery for spinal cord ependymomas: outcome and prognostic factors. Neurosurgery 2011, 68(2):302-308.
• [17]Brotchi J, Fischer G: Spinal cord ependymomas. Neurosurg Focus 1998, 4(5):E2.
• [18]Chang UK, Choe WJ, Chung SK: Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neurooncol 2002, 57(2):133-139.
• [19]Hanbali F, Fourney DR, Marmor E, Suki D, Rhines LD, Weinberg JS, McCutcheon IE, Suk I, Gokaslan ZL: Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery 2002, 51(5):1162-1174.
• [20]Houten JK, Cooper PR: Spinal cord astrocytomas: presentation, management and outcome. J Neurooncol 2000, 47(3):219-224.
• [21]Jallo GI, Danish S, Velasquez L, Epstein F: Intramedullary low-grade astrocytomas: long-term outcome following radical surgery. J Neurooncol 2001, 53(1):61-66.
• [22]Jyothirmayi R, Madhavan J, Nair MK, Rajan B: Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma. J Neurooncol 1997, 33(3):205-211.
• [23]Kim MS, Chung CK, Choe G, Kim IH, Kim HJ: Intramedullary spinal cord astrocytoma in adults: postoperative outcome. J Neurooncol 2001, 52(1):85-94.
• [24]McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI: Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 2008, 63(1):55-61.
• [25]Nishio S, Morioka T, Fujii K, Inamura T, Fukui M: Spinal cord gliomas: management and outcome with reference to adjuvant therapy. J Clin Neurosci 2000, 7(1):20-23.
• [26]Rodrigues GB, Waldron JN, Wong CS, Laperriere NJ: A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int J Radiat Oncol Biol Phys 2000, 48(3):837-842.
• [27]Lee TT, Gromelski EB, Green BA: Surgical treatment of spinal ependymoma and post-operative radiotherapy. Acta Neurochir 1998, 140(4):309-313.
• [28]Isaacson SR: Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol 2000, 47(3):231-238.
• [29]Schwartz TH, McCormick PC: Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 2000, 47(3):211-218.
• [30]Garcia DM: Primary spinal cord tumors treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys 1985, 11(11):1933-1939.
• [31]Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC: CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery 2004, 55(1):89-99.
• [32]Ryu SI, Kim DH, Chang SD: Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus 2003, 15(5):E10.
• [33]Wowra B, Muacevic A, Zausinger S, Tonn JC: Radiosurgery for spinal malignant tumors. Dtsch Arztebl Int 2009, 106(7):106-112.
• [34]Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, Epstein F, Finlay JL: Children’s Cancer Group. Treatment of high-grade spinal cord astrocytoma of childhood with “8-in1” chemotherapy and radiotherapy: a pilot study of CCG-945. J Neurosurg 1998, 88(2):215-220.
• [35]Balmaceda C: Chemotherapy for intramedullary spinal cord tumours. J Neurooncol 2000, 47(3):293-307.
• [36]Doireau V, Grill J, Zerah M, Lellouch-Tubiana A, Couanet D, Chastagner P, Marchal JC, Grignon Y, Chouffai Z, Kalifa C: Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP) Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Br J Cancer 1999, 81(5):835-840.